- Study 2023-60 (collaboration) Clinical effectiveness of respiratory syncitial virus (RSV) vaccines
- Study 2023-51 (HSR) The care of persons with young-onset dementia: a state of play
- Study 2023-13 (HSR) NEED for rare diseases
- Study 2023-12 (HTA) The use of endothelial cell counting in the preoperative evaluation of cataract surgery
- Study 2023-07 (HSR) Endometriosis care in Belgium - a rapid assessment
- Study 2023-02 (HSR) Towards a roadmap for cell & gene therapies developed by universities and non-profit organisations
- Study 2023-01 (HSR) Accountability mechanisms when introducing a DRG-based lump sum payment per case for hospitals in Belgium
- Study 2022-52 (HSR) Indirect costs in hospital financing
- Study 2022-03 (HSR) Tackling unmet needs in healthcare: towards a needs-driven life-cycle approach
- Study 2022-02 (HSR) The place of intermediate palliative care in the Belgian palliative care landscape
- Study 2024-13 (HSR) Performance of the Belgian healthcare system: environmental sustainability
- Study 2024-12 (HTA) Review of new oncology indications for the use of positron emission tomography (PET-scans)
- Study 2024-11 (HTA) Update of breast cancer screening recommendations
- Study 2024-10 (HTA) Update of prostate cancer screening recommendations
- Study 2024-09 (HTA) Economic evaluation of whole genome sequencing for children with developmental disorders
- Study 2024-08 (HSR) Extension of existing indications for proton therapy in Belgium: scientific clinical evidence and funding
- Study 2024-07 (HSR) Evaluation of a case management model for some neurodegenerative diseases
- Study 2024-06 (HSR) Evaluation of NIDIH-funded projects on access to healthcare for vulnerable people
- Study 2024-05 (HSR) Alternative scenarios for projecting the GP workforce
- Study 2024-04 (HSR) Evaluation of home hospitalisation (antibiotics and chemotherapy)